UnitedHealthcare (UHC) is facing a class action lawsuit for allegedly using an artificial intelligence (AI) system, nH Predict, to deny…
Browsing: Hot headlines in GI
A study published in JAMA Network Open, finds that conventional colonoscopy remains the most cost-effective method for universal colorectal cancer…
Universal DX (UDX), a liquid biopsy firm, successfully closes a Series B financing round of approximately $70 million. Key highlights…
The MobiHealthNews article titled “Q&A: The status of the White House-led CancerX initiative” provides an update on the CancerX initiative,…
Over 10% of fecal immunochemical tests (FIT), used for routine colorectal cancer (CRC) screening in a safety-net health system, contained…
Background and Challenges: Hybrid Virtual Care Approach: Implementation and Results: Advice for Other Practices: In essence, Gastroenterology Associates of New…
Researchers at UMass Lowell’s Zuckerberg College of Health Sciences are investigating the connection between the gut microbiome and the risk…
Claris GenomiX, a precision oncology company, has announced the licensing availability of ColoType, its patented mRNA-based Consensus Molecular Subtyping (CMS)…
Biotech company AnchorDx has formed a long-term partnership with molecular diagnostics firm DiaCarta to develop and commercialize cancer diagnostic products…
The CancerX initiative, part of the White House-led Cancer Moonshot program, is making significant strides in advancing cancer care through…